JACQUELINE COLEMAN: Open Payments
NPI 1396466132 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 17 payments from 3 companies in 2025. Trend: 2023 $24 · 2024 $45 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 12 | $172 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
Products named: NUPLAZID, REXULTI, INGREZZA.
Industry payments across FL — which companies pay providers there.
